ENHANCEMENT OF ANTITUMOR EFFECT BY COMBINATION TREATMENT WITH GENETICALLY MODIFIED COXSACKIEVIRUS B3 THAT INDUCES IMMUNOGENIC CELL DEATH AND ANTI-PD-L1 INHIBITOR

Mutsunori Murahashi(Jikei University School of Medicine), Kenzaburo Tani(Tokyo Medical University), S. Miyamoto, MORIJI SAGARA(The University of Tokyo), Yayoi Kamata(Juntendo University), Y. Momoda
Cytotherapy
May 22, 2024
Cited by 0


Related Papers